http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2123860-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_881b5cbebff422bef2c9e47d6771b116
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f657938546cbab49ef40799d30848286
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2de68e1db7f12e5db9bf700900d11e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aba2cfeb75437cf3090c5ca43a5871b7
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57
filingDate 1995-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f35e8160f411e97c2f5a64dc397eabc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a0c294073eae4ee6bc1eae65a878cf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c38f6289f178672df3d313e8e080998d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11c36a3e41446530c5018762b7a75adc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0fbefcda7965632ed18f7ca70205aa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89d3b78635ff170d6b29327fc60ce5d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7213e080c434f4226b80ba51e704c159
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b3364c35b96fa69d87291c8c4785af4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7799beb5712fdf268f65282a14702395
publicationDate 1998-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2123860-C1
titleOfInvention Affine sorbent for removal of tumor necrosis factor and method of its preparing
abstract FIELD: medicine, sorbents. SUBSTANCE: affine sorbent has a carrier containing an immobilized human α 2 --macroglobulin. Method of a sorbent preparing involves immobilization of human α 2 --macroglobulin at pH 7.0-8.2 followed by its treatment with thio-ester loop modifying agent. The latter is monomethylamine hydrochloride or proteolytic enzyme plasmin of human blood plasma. Invention can be used for development of new approaches to treatment of patients with sicknesses caused by massive inflow of cytokines in blood, for example, as a result of septic shock. EFFECT: improved method of sorbent preparing, enhanced effectiveness of sorbent. 4 cl, 4 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2494686-C1
priorityDate 1995-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451256147
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397808
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10476

Total number of triples: 33.